Our findings align with and extend previous research on GSTP1 inhibition, such as studies involving ethacrynic acid (Tew and Gaté, 2001; Potęga 2022) and TLK199 (Lv et al. 2023), which demonstrated the ability of these inhibitors to increase cancer cell sensitivity to chemotherapy. This evidence concerns the gene GSTP1 and cancer.